45280-17-9Relevant articles and documents
A METHOD OF TREATING PERIPHERAL INFLAMMATORY DISEASE
-
Paragraph 0078-0084; 0121-0122, (2016/12/01)
An active for use in the treatment or inhibition of an inflammatory disease associated with over-activation of Toll-like Receptor 4 (TLR4), Toll-like Receptor 2 (TLR2) and Myeloid differentiating protein 88 (Myd88) adaptor-like protein (Mal) while maintaining a subject's ability to respond normally to a pathogen, in which the active is an oleamide or a derivative thereof.
Arachidonic acid amide inhibitors of gap junction cell-cell communication
Boger, Dale L.,Sato, Haruhiko,Lerner, Aaron E.,Guan, Xiaojun,Gilula, Norton B.
, p. 1151 - 1154 (2007/10/03)
A series of arachidonic acid amides including anandamide and arachidonamide that act as potent inhibitors of the rat glial cell gap junction is described.